B-cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B-cells and SARS-CoV-2 neutralizing antibodies. Fox-Fisher et al.

Published: 19 April 2022| Version 1 | DOI: 10.17632/5bmb564d8t.1
Contributor:
ilana fox

Description

The characteristics (age, gender and adverse events) of the participants in this study. raw data of immune derived cfDNA, cell counts and antibodies.

Files

Categories

Vaccination, COVID-19

Licence